Akira Endo
Lua error in Module:Unicode_data at line 293: attempt to index local 'data_module' (a boolean value). was a Japanese biochemist. He was known for his research into the relationship between fungi and cholesterol biosynthesis led to the development of statin drugs.
Akira Endo 遠藤章 | |
|---|---|
 Dr. Endo | |
| Born | 14 November 1933 Higashiyuri (present-day Yurihonjō, Akita) |
| Died | 5 June 2024 (aged 90) Tokyo, Japan |
| Alma mater | Tohoku University, |
| Known for | discovering the first statin (HMG-CoA reductase inhibitor), paving the way for statin drug development |
| Awards | Heinrich Wieland Prize (1987) Japan Prize (2006) Massry Prize (2006) Lasker Award (2008) National Inventors Hall of Fame 2012) Canada Gairdner International Award (2017) |
| Scientific career | |
| Fields | Biochemistry |
| Institutions | Sankyo Co., Tokyo University of Agriculture and Technology |
He received the Japan Prize in 2006,[1] the Lasker-DeBakey Clinical Medical Research Award in 2008,[2] the Canada Gairdner International Award in 2017.
Endo died on 5 June 2024 in Tokyo, Japan at the age of 90.[3]
References
- ↑ The Science and Technology Foundation of Japan. Japan Prize official release Archived 2007-01-10 at the Wayback Machine, accessed 21 June 2006
- ↑ "Lasker~DeBakey Clinical Medical Research Award, 2008: Akira Endo". Archived from the original on 2015-05-22. Retrieved 2018-09-26.
- ↑ Japan Biochemist Who Discovered Statins, Akira Endo, Dies At 90: Colleague